Qingyun Tan

803 total citations · 1 hit paper
19 papers, 594 citations indexed

About

Qingyun Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Qingyun Tan has authored 19 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Qingyun Tan's work include Ferroptosis and cancer prognosis (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Qingyun Tan is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Qingyun Tan collaborates with scholars based in China. Qingyun Tan's co-authors include Qiong Gu, Yuying Fang, Jun Xu, Huihao Zhou, Xiu‐Cai Chen, Xing Peng, De‐Yin Wu, Weibin Bai, Wei Huang and Tianfeng Chen and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, European Journal of Medicinal Chemistry and BioMed Research International.

In The Last Decade

Qingyun Tan

18 papers receiving 590 citations

Hit Papers

Inhibiting Ferroptosis through Disrupting the NCOA4–FTH1 ... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyun Tan China 11 361 335 274 83 38 19 594
Yue‐Chen Zhao China 8 259 0.7× 288 0.9× 218 0.8× 59 0.7× 40 1.1× 22 548
Aryatara Shakya United States 9 279 0.8× 414 1.2× 208 0.8× 31 0.4× 56 1.5× 10 600
Bihui Han China 5 212 0.6× 225 0.7× 164 0.6× 40 0.5× 31 0.8× 6 373
Yanfeng Qi United States 13 556 1.5× 406 1.2× 201 0.7× 114 1.4× 7 0.2× 15 798
Zichao Feng China 12 184 0.5× 464 1.4× 220 0.8× 73 0.9× 161 4.2× 24 748
Xiangru Zheng China 10 106 0.3× 313 0.9× 147 0.5× 39 0.5× 46 1.2× 14 473
Tamás Lőrincz Hungary 14 177 0.5× 268 0.8× 148 0.5× 73 0.9× 136 3.6× 20 622
Chundi Gao China 19 194 0.5× 656 2.0× 426 1.6× 155 1.9× 35 0.9× 47 944
Zhongqiang Guo China 13 98 0.3× 346 1.0× 150 0.5× 90 1.1× 21 0.6× 24 539

Countries citing papers authored by Qingyun Tan

Since Specialization
Citations

This map shows the geographic impact of Qingyun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyun Tan more than expected).

Fields of papers citing papers by Qingyun Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyun Tan. The network helps show where Qingyun Tan may publish in the future.

Co-authorship network of co-authors of Qingyun Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyun Tan. A scholar is included among the top collaborators of Qingyun Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyun Tan. Qingyun Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Xu, Peng, et al.. (2025). Development of potent inhibitors targeting bacterial prolyl-tRNA synthetase through fluorine scanning-directed activity tuning. European Journal of Medicinal Chemistry. 291. 117647–117647.
2.
Tan, Qingyun, et al.. (2024). Oxycodone alleviates LPS-induced neuroinflammation by regulating the CREB/miR-181c/PDCD4 axis. The Journal of Toxicological Sciences. 49(10). 435–446. 1 indexed citations
3.
Tan, Qingyun, et al.. (2024). Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/Prdx3 pathway. DARU Journal of Pharmaceutical Sciences. 32(1). 189–196. 3 indexed citations
4.
Tan, Qingyun, et al.. (2024). Identifying eleven new ferroptosis inhibitors as neuroprotective agents from FDA-approved drugs. Bioorganic Chemistry. 146. 107261–107261. 5 indexed citations
5.
Peng, Xing, et al.. (2023). Chemical constituents of Ajuga forrestii and their anti-ferroptosis activity. Fitoterapia. 166. 105461–105461. 4 indexed citations
6.
Tan, Qingyun, et al.. (2023). Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD. Neurotoxicity Research. 41(5). 471–480. 6 indexed citations
7.
Peng, Xing, Qingyun Tan, Zhikang Zhang, et al.. (2023). Discovery of neo-Clerodane Diterpenoids from Ajuga campylantha as Neuroprotective Agents against Ferroptosis and Neuroinflammation. Journal of Natural Products. 86(8). 2006–2021. 5 indexed citations
8.
Fang, Yuying, Qingyun Tan, Huihao Zhou, Jun Xu, & Qiong Gu. (2022). Discovery and optimization of 2-(trifluoromethyl)benzimidazole derivatives as novel ferroptosis inducers in vitro and in vivo. European Journal of Medicinal Chemistry. 245(Pt 1). 114905–114905. 12 indexed citations
9.
Fang, Yuying, Qingyun Tan, Huihao Zhou, Qiong Gu, & Jun Xu. (2022). Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents. European Journal of Medicinal Chemistry. 231. 114151–114151. 27 indexed citations
10.
Zhu, Xiaowen, et al.. (2022). ANP32E contributes to gastric cancer progression via NUF2 upregulation. Molecular Medicine Reports. 26(3). 6 indexed citations
11.
Peng, Xing, Qingyun Tan, Leiming Wu, et al.. (2022). Ferroptosis Inhibitory Aromatic Abietane Diterpenoids from Ajuga decumbens and Structural Revision of Two 3,4-Epoxy Group-Containing Abietanes. Journal of Natural Products. 85(7). 1808–1815. 15 indexed citations
12.
Wei, Weiwei, et al.. (2021). miR‑486‑5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Molecular Medicine Reports. 24(5). 10 indexed citations
13.
Tan, Qingyun, Yuying Fang, Xing Peng, et al.. (2021). A new ferroptosis inhibitor, isolated from Ajuga nipponensis, protects neuronal cells via activating NRF2-antioxidant response elements (AREs) pathway. Bioorganic Chemistry. 115. 105177–105177. 21 indexed citations
14.
Fang, Yuying, Xiu‐Cai Chen, Qingyun Tan, et al.. (2021). Inhibiting Ferroptosis through Disrupting the NCOA4–FTH1 Interaction: A New Mechanism of Action. ACS Central Science. 7(6). 980–989. 353 indexed citations breakdown →
15.
Peng, Xing, Qingyun Tan, Huihao Zhou, Jun Xu, & Qiong Gu. (2021). Discovery of phloroglucinols from Hypericum japonicum as ferroptosis inhibitors. Fitoterapia. 153. 104984–104984. 21 indexed citations
16.
Tan, Qingyun, Yuying Fang, & Qiong Gu. (2021). Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases. Frontiers in Pharmacology. 12. 657033–657033. 56 indexed citations
17.
Zhang, Yuting, Yuying Fang, Qingyun Tan, et al.. (2021). Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo. European Journal of Medicinal Chemistry. 213. 113185–113185. 16 indexed citations
18.
Tan, Qingyun, et al.. (2020). JMJD1A Represses the Development of Cardiomyocyte Hypertrophy by Regulating the Expression of Catalase. BioMed Research International. 2020(1). 5081323–5081323. 10 indexed citations
19.
Tan, Qingyun, Yanyu Huang, Wei Huang, et al.. (2018). Structure–Activity Relationship Analysis on Antioxidant and Anticancer Actions of Theaflavins on Human Colon Cancer Cells. Journal of Agricultural and Food Chemistry. 67(1). 159–170. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026